Works by Ryu, Dong-Kyun


Results: 3
    1

    Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

    Published in:
    Emerging Microbes & Infections, 2022, v. 11, n. 1, p. 2315, doi. 10.1080/22221751.2022.2117094
    By:
    • Seo, Ji-Min;
    • Kang, Bobin;
    • Song, Rina;
    • Noh, Hanmi;
    • Kim, Cheolmin;
    • Kim, Jong-In;
    • Kim, Minsoo;
    • Ryu, Dong-Kyun;
    • Lee, Min-Ho;
    • Yang, Jeong-Sun;
    • Kim, Kyung-Chang;
    • Lee, Joo-Yeon;
    • Lee, Hansaem;
    • Woo, Hye-Min;
    • Kim, Jun-Won;
    • Choi, Jung-Ah;
    • Song, Manki;
    • Tomaszewska-Kiecana, Monika;
    • Wołowik, Anna;
    • Kulesza, Agnieszka
    Publication type:
    Article
    2
    3